Your browser doesn't support javascript.
loading
Comparable actions of omalizumab on mast cells and basophils.
Serrano-Candelas, E; Martinez-Aranguren, R; Valero, A; Bartra, J; Gastaminza, G; Goikoetxea, M J; Martín, M; Ferrer, M.
Affiliation
  • Serrano-Candelas E; Biochemistry Unit, Faculty of Medicine, University of Barcelona, Barcelona, Spain.
  • Martinez-Aranguren R; Laboratory of Clinical and Experimental Respiratory Immunoallergy, IDIBAPS, Barcelona, Spain.
  • Valero A; Department of Allergy and Clinical Immunology, Clinica Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Spain.
  • Bartra J; Laboratory of Clinical and Experimental Respiratory Immunoallergy, IDIBAPS, Barcelona, Spain.
  • Gastaminza G; Department of Pneumology and Allergy, Immunoallèrgia Respiratòria Clínica I Experimental, IDIBAPS, Hospital Clínic, Barcelona, Spain.
  • Goikoetxea MJ; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Barcelona, Spain.
  • Martín M; Laboratory of Clinical and Experimental Respiratory Immunoallergy, IDIBAPS, Barcelona, Spain.
  • Ferrer M; Department of Pneumology and Allergy, Immunoallèrgia Respiratòria Clínica I Experimental, IDIBAPS, Hospital Clínic, Barcelona, Spain.
Clin Exp Allergy ; 46(1): 92-102, 2016 Jan.
Article in En | MEDLINE | ID: mdl-26509363

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Basophils / Anti-Allergic Agents / Omalizumab / Mast Cells Limits: Humans Language: En Journal: Clin Exp Allergy Journal subject: ALERGIA E IMUNOLOGIA Year: 2016 Type: Article Affiliation country: Spain

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Basophils / Anti-Allergic Agents / Omalizumab / Mast Cells Limits: Humans Language: En Journal: Clin Exp Allergy Journal subject: ALERGIA E IMUNOLOGIA Year: 2016 Type: Article Affiliation country: Spain